Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. - Wikidata - wikimedia - TriplyDB

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

http://www.wikidata.org/entity/Q33711106

about

SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma Global histone post-translational modifications and cancer: Biomarkers for diagnosis, prognosis and treatment?Common features of chromatin in aging and cancer: cause or coincidence?Epigenetics meets radiation biology as a new approach in cancer treatment Systemic therapies for pancreatic cancer--the role of pharmacogenetics The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure Histone methylation: a dynamic mark in health, disease and inheritance The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis Histone H1 phosphorylation in breast cancer dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial.High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.A Chemical Biology Approach to Reveal Sirt6-targeted Histone H3 Sites in Nucleosomes.Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer.Three-dimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression.Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients Cancer epigenetics: linking basic biology to clinical medicine.Chromosome segregation and organization are targets of 5'-Fluorouracil in eukaryotic cells.CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients.Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma Elevated H3K18 acetylation in airway epithelial cells of asthmatic subjects.Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma γ-H2AX and other histone post-translational modifications in the clinic.The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP.Advances in biomarker research for pancreatic cancer.Stabilization of SIRT7 deacetylase by viral oncoprotein HBx leads to inhibition of growth restrictive RPS7 gene and facilitates cellular transformation.Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.Histone modifications and cancer: biomarkers of prognosis?The controversial role of Sirtuins in tumorigenesis - SIRT7 joins the debate.Quantitative Mass Spectrometry Reveals that Intact Histone H1 Phosphorylations are Variant Specific and Exhibit Single Molecule Hierarchical Dependence p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies Treatment of pancreatic cancer: what can we really predict today?Epigenetics, nervous system tumors, and cancer stem cells.Integrative survival-based molecular profiling of human pancreatic cancer.HOXB7 promotes invasion and predicts survival in pancreatic adenocarcinoma.Histone acetylation regulates intracellular pH.Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.Drug metabolism and pancreatic cancer.

P2860

Q24338723-C64D0C62-C928-4699-BBDB-2DDD069B9877 Q26739910-8AEA6423-F63B-4BE0-81E1-75EF7F9B5FC5 Q26775413-6100701B-FA61-466A-87F5-3CD5F0BEF07D Q26864051-78C65AD2-DD9D-4BAC-98C5-2E59667E5C61 Q27014984-B00816DB-93DE-484E-98D2-D8B5222E8520 Q27021716-CAF4E10C-C2FD-44F1-AF86-E375EC3A9EFB Q28084785-259B74A6-2520-4147-AA12-E1744B83B671 Q28263573-E4FBC00D-C5C4-4AE0-BCDE-17C403F16654 Q28387891-B183FE76-3DB6-415C-8BAC-7B8CC63B5EF2 Q31132024-15EF6640-26A9-4779-96B0-D41854D0F390 Q33577337-0B7C823B-5EA8-43E1-B453-C43CA4786086 Q33727842-1A816521-3CA2-4EFA-A58D-4360B1B9C991 Q33778296-ED779241-4475-4B09-9F6E-7D30505BFB06 Q33817548-F00239A3-BE45-4724-87FF-5CCC766F5F05 Q34240470-8C21D1AC-B329-4507-9426-176EE3F369FD Q34734222-7281F2B2-D905-46E1-ACB0-6AF05AE31B94 Q35010007-2D7AA44E-4570-4E83-9D7E-6B42340EA0F1 Q35348043-10E03F9A-550A-4B96-BC3D-8A9CAD23EF02 Q35497934-15B060C6-89B6-4C10-A07E-EEDC9FC74154 Q35574709-13B87A5B-1DE4-4CC1-B1CE-494556679E53 Q35677046-2910FC82-3485-4EE6-A4A1-D0BC62695F4F Q35925026-F7D359B4-D263-4557-9F3D-F0A2A96AFF25 Q35937982-0EA297E0-1B9C-4F3E-96AA-C080EE9F25DE Q36018745-86C14C46-E25A-4466-912C-49C69A078C99 Q36019818-21C67E00-E7EF-4573-86D1-28CE75B2215C Q36106879-F68D9361-3808-4026-A16B-69359847F189 Q36126609-A5B21A9E-3E04-44A4-A992-6B2EC85D1A6A Q36129012-AC0F5724-358B-4051-B03B-51EE85C794A4 Q36135041-E7A1F76D-037C-4511-9529-566A10CEE2FC Q36206499-DC677913-31C3-43D4-B207-912642A65FE8 Q36522775-CA36D54F-5E23-41D7-9FDF-96247DD592F3 Q36745144-9B92D914-9316-494D-BB81-113C70EFFE6A Q36848202-0B3A8925-639F-454A-B0AB-0C792EC5232F Q37129815-7AF3C0CB-7DFD-412D-8BF7-243DA6F2E72E Q37137442-EBAC3075-840A-4AAD-AC35-95AE1ADDBA12 Q37276948-7F9D57A5-C441-4AFF-AE18-5B97AF78E5B3 Q37401868-D92491C8-EBEF-4716-B102-CA46855383FF Q37483746-5D80B796-98FD-4DBF-871F-D344679CC26F Q37521291-6B3A63BB-D07C-46EF-A310-127C58FB6F9C Q37542844-CF561BA0-410C-4CA8-B2FB-5CF2B0C7F868

P2860

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

http://www.wikidata.org/entity/Q33711106

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cellular histone modification ...... inoma: results from RTOG 9704.

@ast

Cellular histone modification ...... inoma: results from RTOG 9704.

@en

type

label

Cellular histone modification ...... inoma: results from RTOG 9704.

@ast

Cellular histone modification ...... inoma: results from RTOG 9704.

@en

prefLabel

Cellular histone modification ...... inoma: results from RTOG 9704.

@ast

Cellular histone modification ...... inoma: results from RTOG 9704.

@en

P1433

Q33711106-081A130C-6980-4455-99D5-6F48D98D62F8

P1476

Q33711106-59E2EEE2-CD78-405D-8475-920785207E71

P2093

Q33711106-020010D5-89D3-4434-BAFA-46C6B71632CC

Q33711106-07B0BA40-2CED-48F5-BC4F-5A248A441705

Q33711106-3DB1216A-C5A3-4E9E-A95C-64BC11F016F3

Q33711106-527B2E36-E8BB-43BF-8A09-E3016BB99072

Q33711106-52D5399D-AF79-4B72-9247-2D0E877D2E77

Q33711106-5AFF694C-E424-496D-9AF8-E8CFCE5105E9

Q33711106-86361AC2-F87D-47A0-8DD0-61247DCBE434

Q33711106-9823893E-1FB3-4F22-83AE-A9BD2BE30B50

Q33711106-A4C49A93-2B9F-4D74-8C50-511CF6244EA6

Q33711106-B2FD5880-128F-4350-95CC-009C86F9BBC7

P2860

Q33711106-01FF612A-5CB1-4D38-84B3-FE2BD0D0C03E

Q33711106-02D4240C-BEC5-4CBE-813E-119CC485EDE0

Q33711106-17FDC536-E518-4CEE-950C-B6CA519DAA6C

Q33711106-18D29204-7B0E-4A09-B2AA-FD7BF5676080

Q33711106-1EFC43B7-0203-4B10-AED0-15B778DF3043

Q33711106-1FE2E3FF-539D-4E77-844C-3C8E6C26C856

Q33711106-346DAC68-FF68-4CC7-84DC-250317D26107

Q33711106-383656F2-957A-475A-8592-593698CC4A23

Q33711106-45791547-A132-452F-8656-2762AC38D7C6

Q33711106-4FD84CD9-E681-4C55-81B0-C18A6E808DA2

P304

Q33711106-9A8F07A3-B3B4-47BE-86F4-3DF5E27D2B7F

P31

Q33711106-3A3D4FA8-E0C0-4B3E-AFF1-7832C074FFC6

P356

Q33711106-418A91B9-B8DF-4165-A3C8-ACEF37D89DE3

P407

Q33711106-327F61BB-8D79-4183-9427-3EEA8AD30169

P433

Q33711106-AB5E2AB3-B8C8-43BF-8F36-F554D844A841

P478

Q33711106-B929069A-C2EA-466C-9394-E86A90E661E5

P50

Q33711106-DECEAADE-8A2A-45C7-A49F-0FCDCF3F0743

P577

Q33711106-87E2E42C-9592-44CE-9CAB-96E05AF64DE1

P5875

Q33711106-BA49D9C3-74BC-448B-9F4E-5C61F9861D44

P698

Q33711106-8024E676-8E9F-4A35-83EA-9D4D700E682B

P921

Q33711106-8DA44BFC-5D86-4D5D-A7A1-04D5015D6EA6

P932

Q33711106-72FFB6F2-02BE-4AC6-8A74-E18E5F1A6C2B

P356

JCO.2009.24.5639

P1433

Journal of Clinical Oncology

P1476

Cellular histone modification ...... inoma: results from RTOG 9704.

@en

P2093

Ananya Manuyakorn

http://www.w3.org/2001/XMLSchema#string

Chandhan Guha

http://www.w3.org/2001/XMLSchema#string

David B Seligson

http://www.w3.org/2001/XMLSchema#string

David W Dawson

http://www.w3.org/2001/XMLSchema#string

Gardenia Cheung-Lau

http://www.w3.org/2001/XMLSchema#string

Howard Reber

http://www.w3.org/2001/XMLSchema#string

James Farrell

http://www.w3.org/2001/XMLSchema#string

Nicole A Dawson

http://www.w3.org/2001/XMLSchema#string

Oscar Joe Hines

http://www.w3.org/2001/XMLSchema#string

Rebecca Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

The cancer epigenome--components and functional correlates

Cancer epigenomics: DNA methylomes and histone-modification maps

The mammalian epigenome

Pancreatic cancer.

Global histone modifications predict prognosis of resected non small-cell lung cancer.

Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.

Genetics and biology of pancreatic ductal adenocarcinoma.

P304

1358-1365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.24.5639

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Siavash K Kurdistani

P577

2010-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41416934

http://www.w3.org/2001/XMLSchema#string

P698

20142597

http://www.w3.org/2001/XMLSchema#string

P921

P932

2834495

http://www.w3.org/2001/XMLSchema#string